Global Insulin Glargine Injection Supply, Demand and Key Producers, 2024-2030

Global Insulin Glargine Injection Supply, Demand and Key Producers, 2024-2030

Page: 104

Published Date: 11 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Insulin Glargine Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

This report studies the global Insulin Glargine Injection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Insulin Glargine Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Insulin Glargine Injection that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Insulin Glargine Injection total production and demand, 2019-2030, (K Units)
Global Insulin Glargine Injection total production value, 2019-2030, (USD Million)
Global Insulin Glargine Injection production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Insulin Glargine Injection consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Insulin Glargine Injection domestic production, consumption, key domestic manufacturers and share
Global Insulin Glargine Injection production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Insulin Glargine Injection production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Insulin Glargine Injection production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Insulin Glargine Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Lilly, Gan & Lee, Tonghua Dongbao Pharmaceutical, HEC Pharm and Boao Bio Harmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Insulin Glargine Injection market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Insulin Glargine Injection Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Insulin Glargine Injection Market, Segmentation by Type
Pre-filled
Ordinary

Global Insulin Glargine Injection Market, Segmentation by Application
Hospital
Clinic

Companies Profiled:
Sanofi
Lilly
Gan & Lee
Tonghua Dongbao Pharmaceutical
HEC Pharm
Boao Bio Harmaceutical

Key Questions Answered
1. How big is the global Insulin Glargine Injection market?
2. What is the demand of the global Insulin Glargine Injection market?
3. What is the year over year growth of the global Insulin Glargine Injection market?
4. What is the production and production value of the global Insulin Glargine Injection market?
5. Who are the key producers in the global Insulin Glargine Injection market?
btl

Table of Contents

1 Supply Summary
1.1 Insulin Glargine Injection Introduction
1.2 World Insulin Glargine Injection Supply & Forecast
1.2.1 World Insulin Glargine Injection Production Value (2019 & 2023 & 2030)
1.2.2 World Insulin Glargine Injection Production (2019-2030)
1.2.3 World Insulin Glargine Injection Pricing Trends (2019-2030)
1.3 World Insulin Glargine Injection Production by Region (Based on Production Site)
1.3.1 World Insulin Glargine Injection Production Value by Region (2019-2030)
1.3.2 World Insulin Glargine Injection Production by Region (2019-2030)
1.3.3 World Insulin Glargine Injection Average Price by Region (2019-2030)
1.3.4 North America Insulin Glargine Injection Production (2019-2030)
1.3.5 Europe Insulin Glargine Injection Production (2019-2030)
1.3.6 China Insulin Glargine Injection Production (2019-2030)
1.3.7 Japan Insulin Glargine Injection Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Insulin Glargine Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Insulin Glargine Injection Major Market Trends

2 Demand Summary
2.1 World Insulin Glargine Injection Demand (2019-2030)
2.2 World Insulin Glargine Injection Consumption by Region
2.2.1 World Insulin Glargine Injection Consumption by Region (2019-2024)
2.2.2 World Insulin Glargine Injection Consumption Forecast by Region (2025-2030)
2.3 United States Insulin Glargine Injection Consumption (2019-2030)
2.4 China Insulin Glargine Injection Consumption (2019-2030)
2.5 Europe Insulin Glargine Injection Consumption (2019-2030)
2.6 Japan Insulin Glargine Injection Consumption (2019-2030)
2.7 South Korea Insulin Glargine Injection Consumption (2019-2030)
2.8 ASEAN Insulin Glargine Injection Consumption (2019-2030)
2.9 India Insulin Glargine Injection Consumption (2019-2030)

3 World Insulin Glargine Injection Manufacturers Competitive Analysis
3.1 World Insulin Glargine Injection Production Value by Manufacturer (2019-2024)
3.2 World Insulin Glargine Injection Production by Manufacturer (2019-2024)
3.3 World Insulin Glargine Injection Average Price by Manufacturer (2019-2024)
3.4 Insulin Glargine Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Insulin Glargine Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Insulin Glargine Injection in 2023
3.5.3 Global Concentration Ratios (CR8) for Insulin Glargine Injection in 2023
3.6 Insulin Glargine Injection Market: Overall Company Footprint Analysis
3.6.1 Insulin Glargine Injection Market: Region Footprint
3.6.2 Insulin Glargine Injection Market: Company Product Type Footprint
3.6.3 Insulin Glargine Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Insulin Glargine Injection Production Value Comparison
4.1.1 United States VS China: Insulin Glargine Injection Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Insulin Glargine Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Insulin Glargine Injection Production Comparison
4.2.1 United States VS China: Insulin Glargine Injection Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Insulin Glargine Injection Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Insulin Glargine Injection Consumption Comparison
4.3.1 United States VS China: Insulin Glargine Injection Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Insulin Glargine Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Insulin Glargine Injection Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Insulin Glargine Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Insulin Glargine Injection Production Value (2019-2024)
4.4.3 United States Based Manufacturers Insulin Glargine Injection Production (2019-2024)
4.5 China Based Insulin Glargine Injection Manufacturers and Market Share
4.5.1 China Based Insulin Glargine Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Insulin Glargine Injection Production Value (2019-2024)
4.5.3 China Based Manufacturers Insulin Glargine Injection Production (2019-2024)
4.6 Rest of World Based Insulin Glargine Injection Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Insulin Glargine Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Insulin Glargine Injection Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Insulin Glargine Injection Production (2019-2024)

5 Market Analysis by Type
5.1 World Insulin Glargine Injection Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Pre-filled
5.2.2 Ordinary
5.3 Market Segment by Type
5.3.1 World Insulin Glargine Injection Production by Type (2019-2030)
5.3.2 World Insulin Glargine Injection Production Value by Type (2019-2030)
5.3.3 World Insulin Glargine Injection Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Insulin Glargine Injection Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Insulin Glargine Injection Production by Application (2019-2030)
6.3.2 World Insulin Glargine Injection Production Value by Application (2019-2030)
6.3.3 World Insulin Glargine Injection Average Price by Application (2019-2030)

7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Insulin Glargine Injection Product and Services
7.1.4 Sanofi Insulin Glargine Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 Lilly
7.2.1 Lilly Details
7.2.2 Lilly Major Business
7.2.3 Lilly Insulin Glargine Injection Product and Services
7.2.4 Lilly Insulin Glargine Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Lilly Recent Developments/Updates
7.2.6 Lilly Competitive Strengths & Weaknesses
7.3 Gan & Lee
7.3.1 Gan & Lee Details
7.3.2 Gan & Lee Major Business
7.3.3 Gan & Lee Insulin Glargine Injection Product and Services
7.3.4 Gan & Lee Insulin Glargine Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Gan & Lee Recent Developments/Updates
7.3.6 Gan & Lee Competitive Strengths & Weaknesses
7.4 Tonghua Dongbao Pharmaceutical
7.4.1 Tonghua Dongbao Pharmaceutical Details
7.4.2 Tonghua Dongbao Pharmaceutical Major Business
7.4.3 Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Product and Services
7.4.4 Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
7.4.6 Tonghua Dongbao Pharmaceutical Competitive Strengths & Weaknesses
7.5 HEC Pharm
7.5.1 HEC Pharm Details
7.5.2 HEC Pharm Major Business
7.5.3 HEC Pharm Insulin Glargine Injection Product and Services
7.5.4 HEC Pharm Insulin Glargine Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 HEC Pharm Recent Developments/Updates
7.5.6 HEC Pharm Competitive Strengths & Weaknesses
7.6 Boao Bio Harmaceutical
7.6.1 Boao Bio Harmaceutical Details
7.6.2 Boao Bio Harmaceutical Major Business
7.6.3 Boao Bio Harmaceutical Insulin Glargine Injection Product and Services
7.6.4 Boao Bio Harmaceutical Insulin Glargine Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Boao Bio Harmaceutical Recent Developments/Updates
7.6.6 Boao Bio Harmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Insulin Glargine Injection Industry Chain
8.2 Insulin Glargine Injection Upstream Analysis
8.2.1 Insulin Glargine Injection Core Raw Materials
8.2.2 Main Manufacturers of Insulin Glargine Injection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Insulin Glargine Injection Production Mode
8.6 Insulin Glargine Injection Procurement Model
8.7 Insulin Glargine Injection Industry Sales Model and Sales Channels
8.7.1 Insulin Glargine Injection Sales Model
8.7.2 Insulin Glargine Injection Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Insulin Glargine Injection Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Insulin Glargine Injection Production Value by Region (2019-2024) & (USD Million)
Table 3. World Insulin Glargine Injection Production Value by Region (2025-2030) & (USD Million)
Table 4. World Insulin Glargine Injection Production Value Market Share by Region (2019-2024)
Table 5. World Insulin Glargine Injection Production Value Market Share by Region (2025-2030)
Table 6. World Insulin Glargine Injection Production by Region (2019-2024) & (K Units)
Table 7. World Insulin Glargine Injection Production by Region (2025-2030) & (K Units)
Table 8. World Insulin Glargine Injection Production Market Share by Region (2019-2024)
Table 9. World Insulin Glargine Injection Production Market Share by Region (2025-2030)
Table 10. World Insulin Glargine Injection Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Insulin Glargine Injection Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Insulin Glargine Injection Major Market Trends
Table 13. World Insulin Glargine Injection Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Insulin Glargine Injection Consumption by Region (2019-2024) & (K Units)
Table 15. World Insulin Glargine Injection Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Insulin Glargine Injection Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Insulin Glargine Injection Producers in 2023
Table 18. World Insulin Glargine Injection Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Insulin Glargine Injection Producers in 2023
Table 20. World Insulin Glargine Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Insulin Glargine Injection Company Evaluation Quadrant
Table 22. World Insulin Glargine Injection Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Insulin Glargine Injection Production Site of Key Manufacturer
Table 24. Insulin Glargine Injection Market: Company Product Type Footprint
Table 25. Insulin Glargine Injection Market: Company Product Application Footprint
Table 26. Insulin Glargine Injection Competitive Factors
Table 27. Insulin Glargine Injection New Entrant and Capacity Expansion Plans
Table 28. Insulin Glargine Injection Mergers & Acquisitions Activity
Table 29. United States VS China Insulin Glargine Injection Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Insulin Glargine Injection Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Insulin Glargine Injection Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Insulin Glargine Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Insulin Glargine Injection Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Insulin Glargine Injection Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Insulin Glargine Injection Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Insulin Glargine Injection Production Market Share (2019-2024)
Table 37. China Based Insulin Glargine Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Insulin Glargine Injection Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Insulin Glargine Injection Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Insulin Glargine Injection Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Insulin Glargine Injection Production Market Share (2019-2024)
Table 42. Rest of World Based Insulin Glargine Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Insulin Glargine Injection Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Insulin Glargine Injection Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Insulin Glargine Injection Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Insulin Glargine Injection Production Market Share (2019-2024)
Table 47. World Insulin Glargine Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Insulin Glargine Injection Production by Type (2019-2024) & (K Units)
Table 49. World Insulin Glargine Injection Production by Type (2025-2030) & (K Units)
Table 50. World Insulin Glargine Injection Production Value by Type (2019-2024) & (USD Million)
Table 51. World Insulin Glargine Injection Production Value by Type (2025-2030) & (USD Million)
Table 52. World Insulin Glargine Injection Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Insulin Glargine Injection Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Insulin Glargine Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Insulin Glargine Injection Production by Application (2019-2024) & (K Units)
Table 56. World Insulin Glargine Injection Production by Application (2025-2030) & (K Units)
Table 57. World Insulin Glargine Injection Production Value by Application (2019-2024) & (USD Million)
Table 58. World Insulin Glargine Injection Production Value by Application (2025-2030) & (USD Million)
Table 59. World Insulin Glargine Injection Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Insulin Glargine Injection Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Insulin Glargine Injection Product and Services
Table 64. Sanofi Insulin Glargine Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. Lilly Basic Information, Manufacturing Base and Competitors
Table 68. Lilly Major Business
Table 69. Lilly Insulin Glargine Injection Product and Services
Table 70. Lilly Insulin Glargine Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Lilly Recent Developments/Updates
Table 72. Lilly Competitive Strengths & Weaknesses
Table 73. Gan & Lee Basic Information, Manufacturing Base and Competitors
Table 74. Gan & Lee Major Business
Table 75. Gan & Lee Insulin Glargine Injection Product and Services
Table 76. Gan & Lee Insulin Glargine Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Gan & Lee Recent Developments/Updates
Table 78. Gan & Lee Competitive Strengths & Weaknesses
Table 79. Tonghua Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Tonghua Dongbao Pharmaceutical Major Business
Table 81. Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Product and Services
Table 82. Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 84. Tonghua Dongbao Pharmaceutical Competitive Strengths & Weaknesses
Table 85. HEC Pharm Basic Information, Manufacturing Base and Competitors
Table 86. HEC Pharm Major Business
Table 87. HEC Pharm Insulin Glargine Injection Product and Services
Table 88. HEC Pharm Insulin Glargine Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. HEC Pharm Recent Developments/Updates
Table 90. Boao Bio Harmaceutical Basic Information, Manufacturing Base and Competitors
Table 91. Boao Bio Harmaceutical Major Business
Table 92. Boao Bio Harmaceutical Insulin Glargine Injection Product and Services
Table 93. Boao Bio Harmaceutical Insulin Glargine Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Global Key Players of Insulin Glargine Injection Upstream (Raw Materials)
Table 95. Insulin Glargine Injection Typical Customers
Table 96. Insulin Glargine Injection Typical Distributors
List of Figure
Figure 1. Insulin Glargine Injection Picture
Figure 2. World Insulin Glargine Injection Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Insulin Glargine Injection Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Insulin Glargine Injection Production (2019-2030) & (K Units)
Figure 5. World Insulin Glargine Injection Average Price (2019-2030) & (US$/Unit)
Figure 6. World Insulin Glargine Injection Production Value Market Share by Region (2019-2030)
Figure 7. World Insulin Glargine Injection Production Market Share by Region (2019-2030)
Figure 8. North America Insulin Glargine Injection Production (2019-2030) & (K Units)
Figure 9. Europe Insulin Glargine Injection Production (2019-2030) & (K Units)
Figure 10. China Insulin Glargine Injection Production (2019-2030) & (K Units)
Figure 11. Japan Insulin Glargine Injection Production (2019-2030) & (K Units)
Figure 12. Insulin Glargine Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 15. World Insulin Glargine Injection Consumption Market Share by Region (2019-2030)
Figure 16. United States Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 17. China Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 18. Europe Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 19. Japan Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 20. South Korea Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 22. India Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Insulin Glargine Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Insulin Glargine Injection Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Insulin Glargine Injection Markets in 2023
Figure 26. United States VS China: Insulin Glargine Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Insulin Glargine Injection Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Insulin Glargine Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Insulin Glargine Injection Production Market Share 2023
Figure 30. China Based Manufacturers Insulin Glargine Injection Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Insulin Glargine Injection Production Market Share 2023
Figure 32. World Insulin Glargine Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Insulin Glargine Injection Production Value Market Share by Type in 2023
Figure 34. Pre-filled
Figure 35. Ordinary
Figure 36. World Insulin Glargine Injection Production Market Share by Type (2019-2030)
Figure 37. World Insulin Glargine Injection Production Value Market Share by Type (2019-2030)
Figure 38. World Insulin Glargine Injection Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Insulin Glargine Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Insulin Glargine Injection Production Value Market Share by Application in 2023
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Insulin Glargine Injection Production Market Share by Application (2019-2030)
Figure 44. World Insulin Glargine Injection Production Value Market Share by Application (2019-2030)
Figure 45. World Insulin Glargine Injection Average Price by Application (2019-2030) & (US$/Unit)
Figure 46. Insulin Glargine Injection Industry Chain
Figure 47. Insulin Glargine Injection Procurement Model
Figure 48. Insulin Glargine Injection Sales Model
Figure 49. Insulin Glargine Injection Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Sanofi
Lilly
Gan & Lee
Tonghua Dongbao Pharmaceutical
HEC Pharm
Boao Bio Harmaceutical
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Insulin Glargine Injection Supply, Demand and Key Producers, 2024-2030

Global Insulin Glargine Injection Supply, Demand and Key Producers, 2024-2030

Page: 104

Published Date: 11 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Insulin Glargine Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

This report studies the global Insulin Glargine Injection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Insulin Glargine Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Insulin Glargine Injection that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Insulin Glargine Injection total production and demand, 2019-2030, (K Units)
Global Insulin Glargine Injection total production value, 2019-2030, (USD Million)
Global Insulin Glargine Injection production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Insulin Glargine Injection consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Insulin Glargine Injection domestic production, consumption, key domestic manufacturers and share
Global Insulin Glargine Injection production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Insulin Glargine Injection production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Insulin Glargine Injection production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Insulin Glargine Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Lilly, Gan & Lee, Tonghua Dongbao Pharmaceutical, HEC Pharm and Boao Bio Harmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Insulin Glargine Injection market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Insulin Glargine Injection Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Insulin Glargine Injection Market, Segmentation by Type
Pre-filled
Ordinary

Global Insulin Glargine Injection Market, Segmentation by Application
Hospital
Clinic

Companies Profiled:
Sanofi
Lilly
Gan & Lee
Tonghua Dongbao Pharmaceutical
HEC Pharm
Boao Bio Harmaceutical

Key Questions Answered
1. How big is the global Insulin Glargine Injection market?
2. What is the demand of the global Insulin Glargine Injection market?
3. What is the year over year growth of the global Insulin Glargine Injection market?
4. What is the production and production value of the global Insulin Glargine Injection market?
5. Who are the key producers in the global Insulin Glargine Injection market?
btl

Table of Contents

1 Supply Summary
1.1 Insulin Glargine Injection Introduction
1.2 World Insulin Glargine Injection Supply & Forecast
1.2.1 World Insulin Glargine Injection Production Value (2019 & 2023 & 2030)
1.2.2 World Insulin Glargine Injection Production (2019-2030)
1.2.3 World Insulin Glargine Injection Pricing Trends (2019-2030)
1.3 World Insulin Glargine Injection Production by Region (Based on Production Site)
1.3.1 World Insulin Glargine Injection Production Value by Region (2019-2030)
1.3.2 World Insulin Glargine Injection Production by Region (2019-2030)
1.3.3 World Insulin Glargine Injection Average Price by Region (2019-2030)
1.3.4 North America Insulin Glargine Injection Production (2019-2030)
1.3.5 Europe Insulin Glargine Injection Production (2019-2030)
1.3.6 China Insulin Glargine Injection Production (2019-2030)
1.3.7 Japan Insulin Glargine Injection Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Insulin Glargine Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Insulin Glargine Injection Major Market Trends

2 Demand Summary
2.1 World Insulin Glargine Injection Demand (2019-2030)
2.2 World Insulin Glargine Injection Consumption by Region
2.2.1 World Insulin Glargine Injection Consumption by Region (2019-2024)
2.2.2 World Insulin Glargine Injection Consumption Forecast by Region (2025-2030)
2.3 United States Insulin Glargine Injection Consumption (2019-2030)
2.4 China Insulin Glargine Injection Consumption (2019-2030)
2.5 Europe Insulin Glargine Injection Consumption (2019-2030)
2.6 Japan Insulin Glargine Injection Consumption (2019-2030)
2.7 South Korea Insulin Glargine Injection Consumption (2019-2030)
2.8 ASEAN Insulin Glargine Injection Consumption (2019-2030)
2.9 India Insulin Glargine Injection Consumption (2019-2030)

3 World Insulin Glargine Injection Manufacturers Competitive Analysis
3.1 World Insulin Glargine Injection Production Value by Manufacturer (2019-2024)
3.2 World Insulin Glargine Injection Production by Manufacturer (2019-2024)
3.3 World Insulin Glargine Injection Average Price by Manufacturer (2019-2024)
3.4 Insulin Glargine Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Insulin Glargine Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Insulin Glargine Injection in 2023
3.5.3 Global Concentration Ratios (CR8) for Insulin Glargine Injection in 2023
3.6 Insulin Glargine Injection Market: Overall Company Footprint Analysis
3.6.1 Insulin Glargine Injection Market: Region Footprint
3.6.2 Insulin Glargine Injection Market: Company Product Type Footprint
3.6.3 Insulin Glargine Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Insulin Glargine Injection Production Value Comparison
4.1.1 United States VS China: Insulin Glargine Injection Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Insulin Glargine Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Insulin Glargine Injection Production Comparison
4.2.1 United States VS China: Insulin Glargine Injection Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Insulin Glargine Injection Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Insulin Glargine Injection Consumption Comparison
4.3.1 United States VS China: Insulin Glargine Injection Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Insulin Glargine Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Insulin Glargine Injection Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Insulin Glargine Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Insulin Glargine Injection Production Value (2019-2024)
4.4.3 United States Based Manufacturers Insulin Glargine Injection Production (2019-2024)
4.5 China Based Insulin Glargine Injection Manufacturers and Market Share
4.5.1 China Based Insulin Glargine Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Insulin Glargine Injection Production Value (2019-2024)
4.5.3 China Based Manufacturers Insulin Glargine Injection Production (2019-2024)
4.6 Rest of World Based Insulin Glargine Injection Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Insulin Glargine Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Insulin Glargine Injection Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Insulin Glargine Injection Production (2019-2024)

5 Market Analysis by Type
5.1 World Insulin Glargine Injection Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Pre-filled
5.2.2 Ordinary
5.3 Market Segment by Type
5.3.1 World Insulin Glargine Injection Production by Type (2019-2030)
5.3.2 World Insulin Glargine Injection Production Value by Type (2019-2030)
5.3.3 World Insulin Glargine Injection Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Insulin Glargine Injection Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Insulin Glargine Injection Production by Application (2019-2030)
6.3.2 World Insulin Glargine Injection Production Value by Application (2019-2030)
6.3.3 World Insulin Glargine Injection Average Price by Application (2019-2030)

7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Insulin Glargine Injection Product and Services
7.1.4 Sanofi Insulin Glargine Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 Lilly
7.2.1 Lilly Details
7.2.2 Lilly Major Business
7.2.3 Lilly Insulin Glargine Injection Product and Services
7.2.4 Lilly Insulin Glargine Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Lilly Recent Developments/Updates
7.2.6 Lilly Competitive Strengths & Weaknesses
7.3 Gan & Lee
7.3.1 Gan & Lee Details
7.3.2 Gan & Lee Major Business
7.3.3 Gan & Lee Insulin Glargine Injection Product and Services
7.3.4 Gan & Lee Insulin Glargine Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Gan & Lee Recent Developments/Updates
7.3.6 Gan & Lee Competitive Strengths & Weaknesses
7.4 Tonghua Dongbao Pharmaceutical
7.4.1 Tonghua Dongbao Pharmaceutical Details
7.4.2 Tonghua Dongbao Pharmaceutical Major Business
7.4.3 Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Product and Services
7.4.4 Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
7.4.6 Tonghua Dongbao Pharmaceutical Competitive Strengths & Weaknesses
7.5 HEC Pharm
7.5.1 HEC Pharm Details
7.5.2 HEC Pharm Major Business
7.5.3 HEC Pharm Insulin Glargine Injection Product and Services
7.5.4 HEC Pharm Insulin Glargine Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 HEC Pharm Recent Developments/Updates
7.5.6 HEC Pharm Competitive Strengths & Weaknesses
7.6 Boao Bio Harmaceutical
7.6.1 Boao Bio Harmaceutical Details
7.6.2 Boao Bio Harmaceutical Major Business
7.6.3 Boao Bio Harmaceutical Insulin Glargine Injection Product and Services
7.6.4 Boao Bio Harmaceutical Insulin Glargine Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Boao Bio Harmaceutical Recent Developments/Updates
7.6.6 Boao Bio Harmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Insulin Glargine Injection Industry Chain
8.2 Insulin Glargine Injection Upstream Analysis
8.2.1 Insulin Glargine Injection Core Raw Materials
8.2.2 Main Manufacturers of Insulin Glargine Injection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Insulin Glargine Injection Production Mode
8.6 Insulin Glargine Injection Procurement Model
8.7 Insulin Glargine Injection Industry Sales Model and Sales Channels
8.7.1 Insulin Glargine Injection Sales Model
8.7.2 Insulin Glargine Injection Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Insulin Glargine Injection Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Insulin Glargine Injection Production Value by Region (2019-2024) & (USD Million)
Table 3. World Insulin Glargine Injection Production Value by Region (2025-2030) & (USD Million)
Table 4. World Insulin Glargine Injection Production Value Market Share by Region (2019-2024)
Table 5. World Insulin Glargine Injection Production Value Market Share by Region (2025-2030)
Table 6. World Insulin Glargine Injection Production by Region (2019-2024) & (K Units)
Table 7. World Insulin Glargine Injection Production by Region (2025-2030) & (K Units)
Table 8. World Insulin Glargine Injection Production Market Share by Region (2019-2024)
Table 9. World Insulin Glargine Injection Production Market Share by Region (2025-2030)
Table 10. World Insulin Glargine Injection Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Insulin Glargine Injection Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Insulin Glargine Injection Major Market Trends
Table 13. World Insulin Glargine Injection Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Insulin Glargine Injection Consumption by Region (2019-2024) & (K Units)
Table 15. World Insulin Glargine Injection Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Insulin Glargine Injection Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Insulin Glargine Injection Producers in 2023
Table 18. World Insulin Glargine Injection Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Insulin Glargine Injection Producers in 2023
Table 20. World Insulin Glargine Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Insulin Glargine Injection Company Evaluation Quadrant
Table 22. World Insulin Glargine Injection Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Insulin Glargine Injection Production Site of Key Manufacturer
Table 24. Insulin Glargine Injection Market: Company Product Type Footprint
Table 25. Insulin Glargine Injection Market: Company Product Application Footprint
Table 26. Insulin Glargine Injection Competitive Factors
Table 27. Insulin Glargine Injection New Entrant and Capacity Expansion Plans
Table 28. Insulin Glargine Injection Mergers & Acquisitions Activity
Table 29. United States VS China Insulin Glargine Injection Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Insulin Glargine Injection Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Insulin Glargine Injection Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Insulin Glargine Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Insulin Glargine Injection Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Insulin Glargine Injection Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Insulin Glargine Injection Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Insulin Glargine Injection Production Market Share (2019-2024)
Table 37. China Based Insulin Glargine Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Insulin Glargine Injection Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Insulin Glargine Injection Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Insulin Glargine Injection Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Insulin Glargine Injection Production Market Share (2019-2024)
Table 42. Rest of World Based Insulin Glargine Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Insulin Glargine Injection Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Insulin Glargine Injection Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Insulin Glargine Injection Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Insulin Glargine Injection Production Market Share (2019-2024)
Table 47. World Insulin Glargine Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Insulin Glargine Injection Production by Type (2019-2024) & (K Units)
Table 49. World Insulin Glargine Injection Production by Type (2025-2030) & (K Units)
Table 50. World Insulin Glargine Injection Production Value by Type (2019-2024) & (USD Million)
Table 51. World Insulin Glargine Injection Production Value by Type (2025-2030) & (USD Million)
Table 52. World Insulin Glargine Injection Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Insulin Glargine Injection Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Insulin Glargine Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Insulin Glargine Injection Production by Application (2019-2024) & (K Units)
Table 56. World Insulin Glargine Injection Production by Application (2025-2030) & (K Units)
Table 57. World Insulin Glargine Injection Production Value by Application (2019-2024) & (USD Million)
Table 58. World Insulin Glargine Injection Production Value by Application (2025-2030) & (USD Million)
Table 59. World Insulin Glargine Injection Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Insulin Glargine Injection Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Insulin Glargine Injection Product and Services
Table 64. Sanofi Insulin Glargine Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. Lilly Basic Information, Manufacturing Base and Competitors
Table 68. Lilly Major Business
Table 69. Lilly Insulin Glargine Injection Product and Services
Table 70. Lilly Insulin Glargine Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Lilly Recent Developments/Updates
Table 72. Lilly Competitive Strengths & Weaknesses
Table 73. Gan & Lee Basic Information, Manufacturing Base and Competitors
Table 74. Gan & Lee Major Business
Table 75. Gan & Lee Insulin Glargine Injection Product and Services
Table 76. Gan & Lee Insulin Glargine Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Gan & Lee Recent Developments/Updates
Table 78. Gan & Lee Competitive Strengths & Weaknesses
Table 79. Tonghua Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Tonghua Dongbao Pharmaceutical Major Business
Table 81. Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Product and Services
Table 82. Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 84. Tonghua Dongbao Pharmaceutical Competitive Strengths & Weaknesses
Table 85. HEC Pharm Basic Information, Manufacturing Base and Competitors
Table 86. HEC Pharm Major Business
Table 87. HEC Pharm Insulin Glargine Injection Product and Services
Table 88. HEC Pharm Insulin Glargine Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. HEC Pharm Recent Developments/Updates
Table 90. Boao Bio Harmaceutical Basic Information, Manufacturing Base and Competitors
Table 91. Boao Bio Harmaceutical Major Business
Table 92. Boao Bio Harmaceutical Insulin Glargine Injection Product and Services
Table 93. Boao Bio Harmaceutical Insulin Glargine Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Global Key Players of Insulin Glargine Injection Upstream (Raw Materials)
Table 95. Insulin Glargine Injection Typical Customers
Table 96. Insulin Glargine Injection Typical Distributors
List of Figure
Figure 1. Insulin Glargine Injection Picture
Figure 2. World Insulin Glargine Injection Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Insulin Glargine Injection Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Insulin Glargine Injection Production (2019-2030) & (K Units)
Figure 5. World Insulin Glargine Injection Average Price (2019-2030) & (US$/Unit)
Figure 6. World Insulin Glargine Injection Production Value Market Share by Region (2019-2030)
Figure 7. World Insulin Glargine Injection Production Market Share by Region (2019-2030)
Figure 8. North America Insulin Glargine Injection Production (2019-2030) & (K Units)
Figure 9. Europe Insulin Glargine Injection Production (2019-2030) & (K Units)
Figure 10. China Insulin Glargine Injection Production (2019-2030) & (K Units)
Figure 11. Japan Insulin Glargine Injection Production (2019-2030) & (K Units)
Figure 12. Insulin Glargine Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 15. World Insulin Glargine Injection Consumption Market Share by Region (2019-2030)
Figure 16. United States Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 17. China Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 18. Europe Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 19. Japan Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 20. South Korea Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 22. India Insulin Glargine Injection Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Insulin Glargine Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Insulin Glargine Injection Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Insulin Glargine Injection Markets in 2023
Figure 26. United States VS China: Insulin Glargine Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Insulin Glargine Injection Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Insulin Glargine Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Insulin Glargine Injection Production Market Share 2023
Figure 30. China Based Manufacturers Insulin Glargine Injection Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Insulin Glargine Injection Production Market Share 2023
Figure 32. World Insulin Glargine Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Insulin Glargine Injection Production Value Market Share by Type in 2023
Figure 34. Pre-filled
Figure 35. Ordinary
Figure 36. World Insulin Glargine Injection Production Market Share by Type (2019-2030)
Figure 37. World Insulin Glargine Injection Production Value Market Share by Type (2019-2030)
Figure 38. World Insulin Glargine Injection Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Insulin Glargine Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Insulin Glargine Injection Production Value Market Share by Application in 2023
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Insulin Glargine Injection Production Market Share by Application (2019-2030)
Figure 44. World Insulin Glargine Injection Production Value Market Share by Application (2019-2030)
Figure 45. World Insulin Glargine Injection Average Price by Application (2019-2030) & (US$/Unit)
Figure 46. Insulin Glargine Injection Industry Chain
Figure 47. Insulin Glargine Injection Procurement Model
Figure 48. Insulin Glargine Injection Sales Model
Figure 49. Insulin Glargine Injection Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Sanofi
Lilly
Gan & Lee
Tonghua Dongbao Pharmaceutical
HEC Pharm
Boao Bio Harmaceutical
jiaGou

Add To Cart

gouMai

Buy Now